이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
에너지 및 환경 · 2019. 2. 20.1 분 읽기
SHINE Medical Isotope Production Facility; Consideration of Approval of Transfer of License and Conforming Amendment
로컬 자동 번역 · 원본 출처 언어
요약
The U.S. Nuclear Regulatory Commission (NRC) received and is considering approval of an application filed by SHINE Medical Technologies, Inc. (SHINE) on December 11, 2018. The application seeks NRC approval of the indirect transfer of Construction Permit No. CPMIF- 001 for the SHINE Medical Isotope Production Facility, currently held by SHINE. The indirect transfer will result from the establishment of a holding company, Illuminated Holdings, Inc. (Illuminated). The NRC is also considering amending Construction Permit No. CPMIF-001 for administrative purposes to reflect the proposed transfer. The application contains sensitive unclassified non-safeguards information (SUNSI).
원본 출처 언어: Federal Register — Nuclear Regulatory Commission원문 발표 열기 →